Development of a flow cytometric method for quantification of BCL-2 family members in chronic lymphocytic leukemia and correlation with sensitivity to BCL-2 family inhibitors-Reference-Cited by-同舟云学术

Development of a flow cytometric method for quantification of BCL-2 family members in chronic lymphocytic leukemia and correlation with sensitivity to BCL-2 family inhibitors

Published:2016-07-04 Issue:5 Volume:92 Page:331-339
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Smith Morey L.¹,Chyla Brenda¹,McKeegan Evelyn¹,Tahir Stephen K.¹

Affiliation:

1. Research and Development, Oncology Discovery, AbbVie, Inc; 1 North Waukegan Rd, North Chicago Illinois 60064

Funder

AbbVie

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference28 articles.

1. Regulating cell death at, on, and in membranes;Chi;Biochim Biophys Acta,2014

2. The BCL-2 family reunion;Chipuk;Mol Cell,2010

3. Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy;Czabotar;Nat Rev Mol Cell Biol,2014

4. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets;Souers;Nat Med,2013

5. ABT-199 (GDC-0199) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL); High complete response rare and durable disease control;Seymour;J Clin Oncol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex fluorescence detection of single-cell droplet microfluidics and its application in quantifying protein expression levels;Biomicrofluidics;2023-12-01

2. Demands and technical developments of clinical flow cytometry with emphasis in quantitative, spectral, and imaging capabilities;Nanotechnology and Precision Engineering;2022-12-01

3. Quantitative flow cytometry leveraging droplet‐based constriction microchannels with high reliability and high sensitivity;Cytometry Part A;2022-11-23

4. Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients;Scientific Reports;2021-06-18

5. References;Flow Cytometry of Hematological Malignancies;2021-04-06